Experts Form Consensus on Indicators of Integration of Oncology, Palliative Care Programs

Share this content:
International experts reached consensus on the makeup of integration of oncology and palliative care.
International experts reached consensus on the makeup of integration of oncology and palliative care.

International experts reached consensus on the makeup of integration of oncology and palliative care, according to a recent article published first online this week in the journal Annals of Oncology.

Forty-seven international experts, predominately from North America and Europe, participated in a Delphi Survey to rate a list of indicators on integration.

The survey consisted of three rounds with five categories: clinical structure, processes, outcomes, education and research. The consensus was met when agreement reached 70% or greater.

The experts reached consensus on 13 major indicators with two on structure (consensus 95-98%), four on processes (consensus 88-98%), three on outcomes (consensus 88-91%) and four on education (consensus 93-100%).

RELATED: Early Palliative Care Linked with Lower Hospital Cost

Out of a scale of 10, major indicators were considered to be clearly stated (9.8), objective (9.4), open to accurate coding (9.5), and applicable to their own countries (9.4).  In addition to major indicators, 30 minor indicators also reached consensus.

The study demonstrates that these indicators can be useful to identify centers to further develop high-quality integration of oncology and palliative care programs.

Reference

  1. Hui D, Bansal S, Strasser F, et al. Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol. 2015. [Epub ahead of print]. doi: 10.1093/annonc/mdv269.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters